🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial will investigate the use of the novel oral IRAK-4 inh...
Status
Suspended
Location
University of Florida
Start Date
2025-04
Trial ID
NCT05669352
Treatments Being Tested
This phase I trial tests the safety, side effects, best dose, and effective...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2025-05-05
Trial ID
NCT06439836
This phase I trial studies the side effects and best dose of CA-4948 when g...
Status
Recruiting
Location
UF Health Cancer Institute - Gainesville
Start Date
2025-06-23
Trial ID
NCT06696768
This is a multicenter, open-label, Phase 1/2a dose escalation and expansion...
Status
Suspended
Location
Moffitt Cancer Center
Start Date
2020-07-06
Trial ID
NCT04278768
Treatments Being Tested
Based on preclinical data from the Lim lab (WUSM), the investigators hypoth...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2026-03-27
Trial ID
NCT07107750
Treatments Being Tested
This is a phase I trial of CA-4948 in combination with FOLFOX/PD-1 inhibito...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2023-06-02
Trial ID
NCT05187182
Treatments Being Tested
This is a multi-center, open-label study to evaluate the safety, pharmacoki...
Status
Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2017-12-28
Trial ID
NCT03328078
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of emavuse...
Status
Suspended
Location
City of Hope Comprehensive Cancer Center
Start Date
2023-06-12
Trial ID
NCT05685602
Anemia in LR-MDS patients...
Status
Terminated
Location
Charité Berlin - Campus Benjamin Franklin, Med. Klinik m. S. Hämatologie, Onkologie, Tumorimmunologie
Start Date
2022-01-01
Trial ID
NCT05178342
Treatments Being Tested
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-06-18
Trial ID
NCT05564390
Treatments Being Tested